Hypertension

>

Latest News

Baxdrostat Granted FDA Priority Review for Hard-to-Control Hypertension, Could Be First-In-Class Therapy / image credit ©Ihsanfrr/stock.adobe.com Generated with AI
Baxdrostat Granted FDA Priority Review for Hard-to-Control Hypertension, Could Be First-In-Class Therapy

December 2nd 2025

The Priority Review decision is based on phase 3 results showing consistent SBP reductions across uncontrolled and treatment-resistant hypertension subgroups.

Rising Youth Hypertension and Its Long-Term Impact on Coronary Disease: Two New Data Sets / image credit ©
Rising Youth Hypertension and Its Long-Term Impact on Coronary Disease: Two New Data Sets

November 20th 2025

Preventive Health Inventory Boosts Diabetes and Hypertension Management Without Increasing Hospitalizations Among Veterans: New Study / Image credit: ©daniel0/AdobeStock
Preventive Health Inventory Boosts Diabetes and Hypertension Management Without Increasing Hospitalizations Among Veterans: New Study

November 18th 2025

Chronic Pain Linked to Greater Risk of Hypertension, Depression Mediates the Relationship / image credit Jill Pell, MD, CBE, Courtesy of the University of Glasgow
Chronic Pain Linked to Greater Risk of Hypertension, Depression Mediates the Relationship

November 17th 2025

CagriSema Reduces SBP by 10.9 mmHg in Post Hoc Analysis of REDEFINE 1 Trial / image credit Subodh Verma, MD, PhD   Courtesy of University of Toronto Cardiac Surgery
CagriSema Reduces SBP by 10.9 mmHg in Post Hoc Analysis of REDEFINE 1 Trial

November 7th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.